STAT+: Top drug regulator is retiring as FDA departures mount
The top drug regulator at the FDA is retiring in July, as departures of senior leaders mount.
WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July.
Corrigan-Curay, who took over as acting director of the Center for Drug Evaluation and Research in January, broke the news to staff in an email shared with STAT. She said she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering support, especially during recent challenging times.”
Top career officials at the FDA have been leaving the agency at a fast clip, with some choosing to take early retirements and others being forced out by political appointees. Few FDA center directors, who have typically stayed under new administrations, remain.
